# Study of Entecavir for Reducing the Risk of Hepatocellular Carcinoma in Chronic Hepatitis B Patients

> **NCT04646928** · — · UNKNOWN · sponsor: **CHA University** · enrollment: 245 (estimated)

## Conditions studied

- Chronic Hepatitis B

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT04646928
- **Lead sponsor:** CHA University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-03-17
- **Primary completion:** 2022-05-28
- **Final completion:** 2022-08-26
- **Target enrollment:** 245 (ESTIMATED)
- **Last updated:** 2020-11-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04646928

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04646928, "Study of Entecavir for Reducing the Risk of Hepatocellular Carcinoma in Chronic Hepatitis B Patients". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04646928. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*